SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-013244
Filing Date
2022-05-20
Accepted
2022-05-20 16:39:44
Documents
82
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q cenb20220331_10q.htm   iXBRL 10-Q 1128812
2 EXHIBIT 31.1 ex_377151.htm EX-31.1 8375
3 EXHIBIT 32.1 ex_377152.htm EX-32.1 4028
  Complete submission text file 0001437749-22-013244.txt   7129704

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cenb-20220331.xsd EX-101.SCH 84622
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cenb-20220331_cal.xml EX-101.CAL 50298
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cenb-20220331_def.xml EX-101.DEF 553508
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cenb-20220331_lab.xml EX-101.LAB 447663
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cenb-20220331_pre.xml EX-101.PRE 582107
76 EXTRACTED XBRL INSTANCE DOCUMENT cenb20220331_10q_htm.xml XML 1085886
Mailing Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9
Business Address 300-3295 QUALITY WAY WINDSOR A6 N8T 3R9 226-344-0660
CEN BIOTECH INC (Filer) CIK: 0001653821 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55557 | Film No.: 22948248
SIC: 2834 Pharmaceutical Preparations